The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling

Endocrinology

Volumn 144, Issue 6, 2003, Pages 2220-2228

  Gáborik, Zsuzsanna ^a   Jagadeesh, Gowraganahalli ^c   Zhang, Meng ^b   Spät, András ^a   Catt, Kevin J ^b   Hunyady, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; INOSITOL PHOSPHATE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; CALCIUM SIGNALING; CELL STRAIN COS7; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; INTERNALIZATION; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; COS CELLS; DNA-BINDING PROTEINS; ENDOCYTOSIS; ETS-DOMAIN PROTEIN ELK-1; GTP-BINDING PROTEINS; INOSITOL PHOSPHATES; KINETICS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TRANSCRIPTION FACTORS;

EID: 0141811657     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-0135     Document Type: Conference Paper

References (68)

1. 1 receptor. Trends Pharmacol Sci 17:135-140
2. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T 2000 International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472
3. Spät A, Enyedi P, Hajnóczky Gy, Hunyady L 1991 Generation and role of calcium signal in adrenal glomerulosa cells. Exp Physiol 76:859-885
4. Eguchi S, Inagami T 2000 Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91:13-20
5. Saito Y, Berk BC 2002 Angiotensin II-mediated signal transduction pathways. Curr Hypertens Rep 4:167-171
6. 1 angiotensin receptor. J Biol Chem 269:31378-31382
7. 1a receptor is localized to a serine/threonine-rich region of its cytoplasmic tail. Mol Pharmacol 54: 935-941
8. 1A) receptor carboxyl terminus: a role in receptor endocytosis. Mol Endocrinol 12:1513-1524
9. 1) receptor function. Regul Pept 79:9-23
10. Hunyady L, Cart KJ, Clark AJ, Gáborik Z 2000 Mechanisms and functions of AT(1) angiotensin receptor internalization. Regul Pept 91:29-44
11. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M 2000 Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289: 739-745
12. Ballesteros JA, Shi L, Javitch JA 2001 Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol 60:1-19
13. Greasley PJ, Fanelli F, Scheer A, Abuin L, Nenniger-Tosato M, DeBenedetti PG, Cotecchia S 2001 Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J Biol Chem 276:46485-46494
14. 135 sequence in rhodopsin. J Biol Chem 271:25406-25411
15. Franke RR, Sakmar TP, Graham RM, Khorana HG 1992 Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J Biol Chem 267:14767-14774
16. 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J 15:3566-3578
17. Scheer A, Fanelli F, Costa T, De Benedetti PG, Cotecchia S 1997 The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94:808-813
18. Rasmussen SG, Jensen AD, Liapakis G, Ghanouni P, Javitch JA, Gether U 1999 Mutation of a highly conserved aspartic acid in the β2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol Pharmacol 56:175-184
19. Alewijnse AE, Timmerman H, Jacobs EH, Smit MJ, Roovers E, Cotecchia S, Leurs R 2000 The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol Pharmacol 57:890-898
20. Arora KK, Cheng Z, Catt KJ 1997 Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Mol Endocrinol 11:1203-1212
21. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E 2002 Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 13:336-343
22. Ballesteros J, Kitanovic S, Guarnieri F, Davies P, Fromme BJ, Konvicka K, Chi L, Millar RP, Davidson JS, Weinstein H, Sealfon SC 1998 Functional microdomains in G-protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J Biol Chem 273:10445-10453
23. Gether U 2000 Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113
24. Oliveira L, Paiva AC, Sander C, Vriend G 1994 A common step for signal transduction in G protein-coupled receptors. Trends Pharmacol Sci 15:170-172
25. 1 receptor. Eur J Pharmacol 288:251-257
26. Zhu SZ, Wang SZ, Hu J, El-Fakahany EE 1994 An argmine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol Pharmacol 45:517-523
27. Chung DA, Wade SM, Fowler CB, Woods DD, Abada PB, Mosberg HI, Neubig RR 2002 Mutagenesis and peptide analysis of the DRY motif in the alpha2A adrenergic receptor: evidence for alternate mechanisms in G protein-coupled receptors. Biochem Biophys Res Commun 293:1233-1241
28. Fanelli F, Menziani C, Scheer A, Cotecchia S, De Benedetti PG 1999 Theoretical study of the electrostatically driven step of receptor-G protein recognition. Proteins 37:145-156
29. Burstein ES, Spalding TA, Brann MR 1998 The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling. J Biol Chem 273:24322-24327
30. Moro O, Lameh J, Högger P, Sadée W 1993 Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J Biol Chem 268: 22273-22276
31. Arora KK, Sakai A, Catt KJ 1995 Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor. J Biol Chem 270:22820-22826
32. Smit MJ, Roovers E, Timmerman H, Van De Vrede Y, Alewijnse AE, Leurs R 1996 Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 -> Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists. J Biol Chem 271:7574-7582
33. Erlenbach I, Kostenis E, Schmidt C, Serradeil-Le Gal C, Raufaste D, Dumont ME, Pausch MH, Wess J 2001 Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis. J Biol Chem 276:29382-29392
34. Ohyama K, Yamano Y, Chaki S, Kondo T, Inagami T 1992 Domains for G-protein coupling in angiotensin II receptor type I: studies by site-directed mutagenesis. Biochem Biophys Res Commun 189:677-683
35. Ohyama K, Yamano Y, Sano T, Nakagomi Y, Wada M, Inagami T 2002 Role of the conserved DRY motif on G protein activation of rat angiotensin II receptor type 1A. Biochem Biophys Res Commun 292:362-367
36. Miura S, Zhang J, Karnik SS 2000 Angiotensin II type 1 receptor-function affected by mutations in cytoplasmic loop CD. FEBS Lett 470:331-335
37. Hunyady L, Baukal AJ, Balla T, Catt KJ 1994 Independence of type 1 angiotensin II receptor endocytosis from G protein coupling and signal transduction. J Biol Chem 269:24798-24804
38. Munson PJ, Rodbard D 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
39. Gáborik Z, Szaszák M, Szidonya L, Balla B, Paku S, Catt KJ, Clark AJL, Hunyady L 2001 β-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol Pharmacol 59:239-247
40. Hunyady L, Bor M, Baukal AJ, Balla T, Catt KJ 1995 A conserved NPLFY sequence contributes to agonist binding and signal transduction but is not an internalization signal for the type 1 angiotensin II receptor. J Biol Chem 270: 16602-16609
41. Krupnick JG, Benovic JL 1998 The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319
42. Seta K, Nanamori M, Modrall JG, Neubig RR, Sadoshima J 2002 AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem 277:9268-9277
43. Wess J 1998 Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol Ther 80:231-264
44. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC 1992 Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11:1-20
45. Luttrell LM, Ferguson SSG, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ 1999 β-arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 283:655-661
46. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM 2002 βArrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277:9429-9436
47. 1A angiotensin receptor plays a key role in G protein coupling specificity and transduction of the mitogenic signal. J Biol Chem 272:25566-25572
48. Scheer A, Fanelli F, Diviani D, De Benedetti PG, Cotecchia S 1999 Structure-function relationships of the alpha1b-adrenergic receptor. Eur Urol 36(Suppl 1):11-16
49. Miura S, Feng YH, Husain A, Karnik SS 1999 Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor. J Biol Chem 274:7103-7110
50. Parnot C, Bardin S, Miserey-Lenkei S, Guedin D, Corvol P, Clauser E 2000 Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay. Proc Natl Acad Sci USA 97:7615-7620
51. Savarese TM, Fraser CM 1992 In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J 283:1-19
52. Baldwin JM 1993 The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-1703
53. Franke RR, König B, Sakmar TP, Khorana HG, Hofmann KP 1990 Rhodopsin mutants that bind but fail to activate transducin. Science 250:123-125
54. Ernst OP, Hofmann KP, Sakmar TP 1995 Characterization of rhodopsin mutants that bind transducin but fail to induce GTP nucleotide uptake. Classification of mutant pigments by fluorescence, nucleotide release, and flash-induced light-scattering assays. J Biol Chem 270:10580-10586
55. Prossnitz ER, Schreiber RE, Bokoch GM, Ye RD 1995 Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate. J Biol Chem 270:10686-10694
56. Greasley PJ, Fanelli F, Rossier O, Abuin L, Cotecchia S 2002 Mutagenesis and modelling of the α(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol Pharmacol 61:1025-1032
57. Lu ZL, Curtis CA, Jones PG, Pavia J, Hulme EC 1997 The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. Mol Pharmacol 51:234-241
58. 1A angiotensin II receptor induces its constitutive activation. J Biol Chem 272: 1822-1826
59. nY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Mol Pharmacol 49:89-95
60. 1a angiotensin receptor. FEBS Lett 428:147-151
61. Sano T, Ohyama K, Yamano Y, Nakagomi Y, Nakazawa S, Kikyo M, Shirai H, Blank JS, Exton JH, Inagami T 1997 A domain for G protein coupling in carboxyl-terminal tail of rat angiotensin II receptor type 1A. J Biol Chem 272:23631-23636
62. Wilbanks AM, Laporte SA, Bohn LM, Barak LS, Caron MG 2002 Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors. Biochemistry 41:11981-11989
63. Farrens DL, Altenbach C, Yang K, Hubbell WL, Khorana HG 1996 Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274:768-770
64. Hunyady L, Gáborik Z, Vauquelin G, Catt KJ 2001 Structural requirements for signalling and regulation of AT1-receptors. J Renin Angiotensin Aldosterone Syst 2:S16-S23
65. Ridge KD, Zhang C, Khorana HG 1995 Mapping of the amino acids in the cytoplasmic loop connecting helices C and D in rhodopsin: chemical reactivity in the dark state following single cysteine replacements. Biochemistry 34: 8804-8811
66. Iida-Klein A, Guo J, Takemura M, Drake MT, Potts Jr JT, Abou-Samra A, Bringhurst FR, Segre GV 1997 Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J Biol Chem 272: 6882-6889
67. Liu J, Wess J 1996 Different single receptor domains determine the distract G protein coupling profiles of members of the vasopressin receptor family. J Biol Chem 271:8772-8778
68. Smith RD, Baukal AJ, Dent P, Catt KJ 1999 Raf-1 kinase activation by angiotensin II in adrenal glomerulosa cells: roles of Gi, phosphatidylinositol 3-kinase, and Ca2+ influx. Endocrinology 140:1385-1391